AB PHARMA LTD has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are YUHAN CORP, XI NING and DELTA PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Israel | 2 | |
#5 | Brazil | 1 | |
#6 | Hungary | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | Malaysia | 1 | |
#10 | Peru | 1 | |
#11 | Russian Federation | 1 | |
#12 | WIPO (World Intellectual Property Organization) | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Zhan Zheng-Yun James | 9 |
#2 | Zhan Zheng-Yun J | 5 |
#3 | Zheng- Yun James Zhan | 1 |
#4 | Zheng-Yun James Zhan | 1 |
#5 | Zhan Zheng Yun James | 1 |
Publication | Filing date | Title |
---|---|---|
WO2018209667A1 | Crystal form of polycyclic heterocyclic compound, preparation method therefor, applications thereof and composition thereof | |
CA2788155A1 | Polyheterocyclic compounds highly potent as hcv inhibitors |